Psychiatric Times December 9, 2024
NIH directors discuss initiatives, advances, and more at the annual meeting.
CONFERENCE REPORTER
The 63rd Annual Meeting of the American College of Neuropsychopharmacology (ACNP) featured an in-depth discussion with directors from key National Institutes of Health, highlighting research and strategic priorities in psychiatry, mental health, and neuropsychopharmacology.1 Moderated by Helen Mayberg, MD, ACNP president and director at the Center of Advanced Circuit Therapeutics at the Icahn School of Medicine at Mount Sinai in New York, the panel included George Koob, PhD, director of the National Institute on Alcohol Abuse and Alcoholism (NIAAA); Nora Volkow, MD, director of the National Institute on Drug Abuse (NIDA); Shelli Avenevoli, PhD, acting director of the National Institute of Mental Health (NIMH); Andrea Beckel-Mitchener, PhD,...
Today's Sponsors
Today's Sponsor